Drug Information Association Logo

Recent Developments in Scaled Average Bioequivalence

Time

Wed, Jun 18 7:15AM
W 02

Title

Recent Developments in Scaled Average Bioequivalence

Abstract Summary

The 2 implementations of the scaling approach (FDA, EMA) will be described and compared. Data collected at Algorithme Pharma will then be used to illustrate the diffrences in the 2 implementations and to show the reduction in sample size resulting from it.

Poster Presenter

Pascal Guibord
MSc,
Director, Biometrics,
Algorithme Pharma Inc.
Canada